Brief: Bioage Announces Pricing Of Upsized $115 Million Public Offering
22/01/2026 03:30
Jan 21 (Reuters) - BIOAGE Labs Inc BIOA.O: BIOAGE ANNOUNCES PRICING OF UPSIZED $115.0 MILLION PUBLIC OFFERING BIOAGE LABS INC - PRICES UPSIZED PUBLIC OFFERING AT $19.50 PER SHARE Source text: ID:nGNX3gznfV Further company coverage: BIOA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioAge Labs
See all newsBrief: Bioage Labs Announces First Participant Dosed In Quell-Dme, A Phase 2 Trial Of Bge-102, A Novel Oral Nlrp3 Inhibitor, In Diabetic Macular Edema
BioAge Labs, Inc. reports results for the quarter ended June 30 - Earnings Summary
BioAge Labs Q1 collaboration revenue beats estimates on Novartis collaboration
BioAge Labs full-year collaboration revenue beats estimates
U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP